G Protein-Coupled Receptor Kinase/β-Arrestin Systems and Drugs of Abuse: Psychostimulant and Opiate Studies in Knockout Mice

NeuroMolecular Medicine

Volumn 5, Issue 1, 2004, Pages 41-50

  Bohn, Laura M ^a   Gainetdinov, Raul R ^b   Caron, Marc G ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Addiction; Amphetamine; Arrestin; Cocaine; Desensitization; Drug abuse; G protein coupled receptor (GPCR); GPCR kinase (GRK); Knockout mice; Morphine

Indexed keywords

AMPHETAMINE; ANTINOCICEPTIVE AGENT; APOMORPHINE; BETA ARRESTIN; COCAINE; DOPAMINE RECEPTOR; ENKEPHALIN DERIVATIVE; ETORPHINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; MORPHINE; OPIATE; OPIATE DERIVATIVE; PSYCHOSTIMULANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE TREATMENT; DRUG RECEPTOR BINDING; DRUG TARGETING; ENZYME ANALYSIS; LONG TERM EXPOSURE; MOUSE; NONHUMAN; OPIATE ADDICTION; PAIN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REINFORCEMENT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 1642371042     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/nmm:5:1:041     Document Type: Review

References (64)

1. Arden, J. R., Segredo, V., Wang, Z., Lameh, J., Sadee, W. (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65, 1636-1645.
2. Attramadal, H., Arriza, J. L., Aoki, C., et al. (1992) Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J. Biol. Chem. 267, 17882-17890.
3. Barrett, T. B., Hauger, R. L., Kennedy, J. L., et al. (2003) Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol. Psychiatry 8, 546-557.
4. Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J., Caron, M. G. (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723.
5. Bohn, L. M., Gaintedinov, R. R., Sotnikova, T. D., et al. (2003) Enhanced rewarding properties of morphine but not cocaine, in Barrestin-2 knock-out mice. J. Neurosci. 23, 10,265-10,273.
6. Bohn, L. M., Lefkowitz, R. J., Caron, M. G. (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J. Neurosci. 22, 10494-10500.
7. Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., Lin, F. T. (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286, 2495-2498.
8. Carlsson, A. (2001) A paradigm shift in brain research. Science 294, 1021-1024.
9. Conner, D. A., Mathier, M. A., Mortensen, R. M., et al. (1997) beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ. Res. 81, 1021-1026.
10. De Vries, L., Zheng, B., Fischer, T., Elenko, E., Farquhar, M. G. (2000) The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40, 235-271.
11. Di Chiara, G., Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85, 5274-5278.
12. Dohlman, H. G., Thorner, J. (1997) RGS proteins and signaling by heterotrimeric G proteins. J. Biol. Chem. 272, 3871-3874.
13. Erdtmann-Vourliotis, M., Mayer, P., Ammon, S., Riechert, U., Hollt, V. (2001) Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res. Mol. Brain Res. 95, 129-137.
14. Ferguson, S. S., Zhang, J., Barak, L. S., Caron, M. G. (1998) Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci. 62, 1561-1565.
15. Gainetdinov, R. R., Bohn, L. M., Sotnikova, T. D., et al. (2003) Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38, 291-303.
16. Gainetdinov, R. R., Bohn, L. M., Walker, J. K., et al. (1999) Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24, 1029-1036.
17. Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., Caron, M. G. (2004) Desensitization of G protein-coupled receptors and neuronal functions. Ann. Rev. Neurosci. 27, in press.
18. Gainetdinov, R. R., Premont, R. T., Caron, M. G., Lefkowitz, R. J. (2000) Reply: receptor specificity of G-protein-coupled receptor kinases. Trends Pharmacol. Sci. 21, 366-367.
19. Gurevich, E. V., Benovic, J. L., Gurevich, V. V. (2002) Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109, 421-436.
20. Haberstock-Debic, H., Wein, M., Barrot, M., et al. (2003) Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J. Neurosci. 23, 4324-4332.
21. He, M., Shippenberg, T. S. (2000) Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum. J. Pharmacol. Exp. Ther. 293,121-127.
22. Hurle, M. A. (2001) Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and super-sensitivity. J. Neurochem. 77, 486-492.
23. Hyman, S. E., Malenka, R. C. (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695-703.
24. Iacovelli, L., Salvatore, L., Capobianco, L., et al. (2003) Role of G protein-coupled receptor kinase 4 and beta-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases. J. Biol. Chem. 278, 12433-12442.
25. Ito, K., Haga, T., Lameh, J., Sadee, W. (1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur. J. Biochem. 260, 112-119.
26. Iwata, K., Ito, K., Fukuzaki, A., Inaki, K., Haga, T. (1999) Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur. J. Biochem. 263, 596-602.
27. Jaber, M., Koch, W. J., Rockman, H., et al. (1996) Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. USA. 93, 12974-12979.
28. Jenner, P., Marsden, C. D. (1987) Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 26, 931-940.
29. Keith, D. E., Murray, S. R., Zaki, P. A., et al. (1996) Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024.
30. Kieffer, B. L. (1999) Opioids: first lessons from knock-out mice. Trends Pharmacol. Sci. 20, 19-26.
31. Kim, K. M., Valenzano, K. J., Robinson, S. R., Yao, W. D., Barak, L. S., Caron, M. G. (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J. Biol. Chem. 276, 37409-37414.
32. Kirkpatrick, B., Alphs, L., Buchanan, R. W. (1992) The concept of supersensitivity psychosis. J. Nerv. Ment. Dis. 180, 265-270.
33. Kovoor, A., Celver, J. P., Wu, A., Chavkin, C. (1998) Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol. Pharmacol. 54, 704-711.
34. Laakso, A., Mohn, A. R., Gainetdinov, R. R., Caron, M. G. (2002) Experimental genetic approaches to addiction. Neuron 36, 213-228.
35. Lefkowitz, R. J. (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273, 18677-18680.
36. Loh, H. H., Liu, H. C., Cavalli, A., Yang, W., Chen, Y. F., Wei, L. N. (1998) mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54, 321-326.
37. Luttrell, L. M., Lefkowitz, R. J. (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455-465.
38. Mansour, A., Watson, S. J., Akil, H. (1995) Opioid receptors: past, present and future. Trends Neurosci. 18, 69-70.
39. Matthes, H. W., Maldonado, R., Simonin, F., et al. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823.
40. Missale, C., Nash, S. R., Robinson, S. W., Jaber, M., Caron, M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
41. Murphy, N. P., Lam, H. A., Maidment, N. T. (2001) A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J. Neurochem. 79, 626-635.
42. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128.
43. Nestler, E. J., Aghajanian, G. K. (1997) Molecular and cellular basis of addiction. Science 278, 58-63.
44. Nestler, E. J., Landsman, D. (2001) Learning about addiction from the genome. Nature 409, 834-835.
45. Ng, G. Y., Mouillac, B., George, S. R., et al. (1994) Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur. J. Pharmacol. 267, 7-19.
46. Noble, F., Cox, B. M. (1996) Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol. 117, 161-169.
47. Pandey, G. N., Garver, D. L., Tamminga, C., Ericksen, S., Ali, S. I., Davis, J. M. (1977) Postsynaptic super-sensitivity in schizophrenia. Am. J. Psychiatry. 134, 518-522.
48. Peppel, K., Boekhoff, I., McDonald, P., Breer, H., Caron, M. G., Lefkowitz, R. J. (1997) G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J. Biol. Chem. 272, 25425-25428.
49. Picetti, R., Saiardi, A., Abdel Samad, T., Bozzi, Y., Baik, J. H., Borrelli, E. (1997) Dopamine D2 receptors in signal transduction and behavior. Crit. Rev. Neurobiol. 11, 121-142.
50. Pitcher, J. A., Freedman, N. J., Lefkowitz, R. J. (1998) G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653-692.
51. Pontieri, F. E., Tanda, G., Di Chiara, G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA. 92, 12304-12308.
52. Premont, R. T., Inglese, J., Lefkowitz, R. J. (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9,175-182.
53. Rahman, Z., Schwarz, J., Gold, S. J., et al. (2003) RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38, 941-952.
54. Sibley, D. R. (1999) New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu. Rev. Pharmacol. Toxicol. 39, 313-341.
55. Sim, L. J., Selley, D. E., Dworkin, S. I., Childers, S. R. (1996) Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgam-maS autoradiography in rat brain. J. Neurosci. 16, 2684-2692.
56. Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E., Jr., Coyle, J. T. (1982) Dopaminergic dsyfunction in Tourette syndrome. Ann. Neurol. 12, 361-366.
57. Sora, I., Takahashi, N., Funada, M., et al. (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA. 94, 1544-1549.
58. Sternini, C., Spann, M., Anton, B., et al. (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA. 93, 9241-9246.
59. Terwilliger, R. Z., Ortiz, J., Guitart, X., Nestler, E. J. (1994) Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus. J. Neurochem. 63, 1983-1986.
60. Tiberi, M., Nash, S. R., Bertrand, L., Lefkowitz, R. J., Caron, M. G. (1996) Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 271, 3771-3778.
61. Wang, Y. M., Gainetdinov, R. R., Fumagalli, F., et al. (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and super-sensitivity to cocaine and amphetamine. Neuron 19, 1285-1296.
62. Whistler, J. L., von Zastrow, M. (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. USA. 95, 9914-9919.
63. Zhang, J., Ferguson, S. S., Barak, L. S., Aber, M. J., Giros, B., Lefkowitz, R. J., Caron, M. G. (1997) Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization. Receptors Channels 5, 193-199.
64. Zhang, J., Ferguson, S. S., Barak, L. S., et al. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA. 95, 7157-7162.